Viewing StudyNCT00111007



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00111007
Status: COMPLETED
Last Update Posted: 2014-10-31
First Post: 2005-05-16

Brief Title: A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
Sponsor: Bayer
Organization: Bayer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-05
Start Date Type: None
Primary Completion Date: 2006-09
Primary Completion Date Type: ACTUAL
Completion Date: 2009-01
Completion Date Type: ACTUAL
First Submit Date: 2005-05-16
First Submit QC Date: May 16 2005
Study First Post Date: 2005-05-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2011-02-23
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-10-23
Last Update Post Date: 2014-10-31
Last Update Post Date Type: ESTIMATED